Official source
Open official text
The following is a translation of the policy interpretation published by the Guangdong Medical Products Administration on July 30, 2026, regarding the NMPA Announcement on Cosmetic Registration and Filing (2026 No. 70). 1. Background and purpose: On November 17, 2025, the NMPA issued the Opinions on Deepening Cosmetic Regulatory Reform and Promoting High-Quality Industry Development (Guo Yao Jian Zhuang [2025] No. 18), which proposed measures to improve registration and filing efficiency, encourage first launches of new cosmetics in China, optimize…
Dual brief
Business Impact
The National Medical Products Administration has issued an interpretation of its 2026 Announcement No. 70, which introduces measures to streamline cosmetic registration and filing. These include waiving animal testing data for certain product categories, allowing sharing of safety and efficacy data for similar formulations, and simplifying documentation for international product launches and cross-border production transfers. Companies should review the new…
Public article